Sanofi-Aventis U.S. LLC et al v. MSN Pharmaceuticals, Inc. et al > Summary
Court Case Number 1:20-cv-00646
Filing Date May 14, 2020
Termination Date Aug 11, 2020
Court Delaware District Court
Status Dismissed - Settled
Appeal2023-2264
JudgesRichard G. Andrews
Plaintiff Attorneys
9Sanofi
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Sanofi
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
SANOFI MATURE IP
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
SANOFI MATURE IP
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
Sanofi
Attorney Name: William E. Solander
Venable
Sanofi
Attorney Name: Daniel J. Minion
Venable
Sanofi
Attorney Name: Whitney M. Howard
Venable
Sanofi
Attorney Name: Michael S. Scerbo
Venable
Defendant Attorneys
8MSN Laboratories
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
MSN Pharmaceuticals Inc.
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
MSN Laboratories
Attorney Name: Richard C. Weinblatt
Stamoulis & Weinblatt
MSN Pharmaceuticals Inc.
Attorney Name: Richard C. Weinblatt
Stamoulis & Weinblatt
MSN Laboratories
Attorney Name: Ronald M. Daignault
Goldberg Segalla LLP
MSN Pharmaceuticals Inc.
Attorney Name: Ronald M. Daignault
Goldberg Segalla LLP
MSN Laboratories
Attorney Name: Richard Juang
Goldberg Segalla LLP
MSN Pharmaceuticals Inc.
Attorney Name: Richard Juang
Goldberg Segalla LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10583110 | Antitumoral use of cabazitaxel | Mar 10, 2020 |
